Приказ основних података о документу

Pregled mogućnosti primene natkritičnog ugljenik(IV)-oksida u proizvodnji lekova

dc.creatorMilovanović, Stoja
dc.creatorLukić, Ivana
dc.date.accessioned2023-03-02T11:48:48Z
dc.date.available2023-03-02T11:48:48Z
dc.date.issued2022
dc.identifier.issn0004-1963
dc.identifier.urihttp://TechnoRep.tmf.bg.ac.rs/handle/123456789/5962
dc.description.abstractSupercritical carbon dioxide (scCO2) application in the pharmaceutical industry is still undeveloped regardless of significant research interests in this processing medium shown in the last decades. ScCO2 technologies can improve drug solubility, bioavailability, and therapeutic effect. These technologies can lead to the development of new formulations that will contribute to a decrease in drug dose, medication frequency, and increase patients’ well-being. Considering the significant decrease in the price of high-pressure equipment and society's growing need for cleaner production and safer products, it is expected that symbiosis between supercritical fluid and pharmaceutical technologies will happen soon. Therefore, this review was focused on the latest contributions of scCO2 technologies to the pharmaceutical field. The main aim was to bring these technologies closer to pharmaceutical specialists. For this purpose, the most commonly used technologies were explained and discussed: the preparation of solid dispersions, polymer impregnation with drugs, and drug micro/nanoparticle production using scCO2.sr
dc.language.isoensr
dc.publisherPharmaceutical Association of Serbiasr
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200135/RS//sr
dc.rightsopenAccesssr
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/
dc.sourceArhiv za Farmacijusr
dc.subjectparticle generationsr
dc.subjectsolid dispersionsr
dc.subjectsupercritical CO2sr
dc.subjectsupercritical impregnationsr
dc.titleAn overview on the application of supercritical carbon dioxide for the processing of pharmaceuticalssr
dc.titlePregled mogućnosti primene natkritičnog ugljenik(IV)-oksida u proizvodnji lekovasr
dc.typearticlesr
dc.rights.licenseBY-NC-SAsr
dc.citation.epage590
dc.citation.issue6
dc.citation.rankM51
dc.citation.spage566
dc.citation.volume72
dc.identifier.doi10.5937/ARHFARM72-39999
dc.identifier.fulltexthttp://TechnoRep.tmf.bg.ac.rs/bitstream/id/15796/0004-19632206566M.pdf
dc.identifier.scopus2-s2.0-85148212305
dc.type.versionpublishedVersionsr


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу